No association of MDM2 SNP309 with risk of glioblastoma and prognosis

被引：0
|
作者：
Soufiane El Hallani
Yannick Marie
Ahmed Idbaih
Mathieu Rodero
Blandine Boisselier
Florence Laigle-Donadey
François Ducray
Jean-Yves Delattre
Marc Sanson
机构：
[1] INSERM,Faculté de Médecine
[2] U711,Laboratoire d’Immunologie Cellulaire
[3] Biologie des Interactions Neurones & Glie,undefined
[4] Université Pierre et Marie Curie,undefined
[5] AP-HP,undefined
[6] Groupe Hospitalier Pitié-Salpêtrière,undefined
[7] Service de Neurologie Mazarin,undefined
[8] INSERM U543,undefined
来源：
Journal of Neuro-Oncology | 2007年 / 85卷
关键词：
Glioblastoma; MDM2; Polymorphism; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The MDM2 SNP309 variant has been shown to increase MDM2 expression and to be associated with tumor formation. In glioblastomas, the P53/MDM2 pathway is of crucial importance and MDM2 amplification is related to poor prognosis. However, we show here that MDM2 SNP309 is not associated with glioblastoma risk, and is not a prognostic factor.
引用
收藏
页码：241 / 244
页数：3
相关论文
共 50 条
  • [41] MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer
    Ryan, Brid M.
    Calhoun, Kara M.
    Pine, Sharon R.
    Bowman, Elise D.
    Robles, Ana I.
    Ambs, Stefan
    Harris, Curtis C.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (11) : 2710 - 2716
  • [42] MDM2 SNP309 Polymorphism and Colorectal Cancer Risk: Appraisal of a Recent Meta-Analysis
    Tian, Jing
    Pan, Feng
    Pan, Yueyin
    Zhang, Ying
    DNA AND CELL BIOLOGY, 2012, 31 (03) : 269 - 270
  • [43] Meta-analysis of associations between MDM2 SNP309 polymorphism and gastric cancer risk
    Chen, Weifeng
    Wu, Qianlan
    Ren, Hongbo
    BIOMEDICAL REPORTS, 2014, 2 (01) : 105 - 111
  • [44] Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon
    Gansmo, Liv B.
    Knappskog, Stian
    Romundstad, Pal
    Hveem, Kristian
    Vatten, Lars
    Lonning, Per E.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (01) : 96 - 103
  • [45] Increased MDM2 expression is associated with inferior survival in mantle cell lymphoma, but not related to the MDM2 SNP309
    Hartmann, Elena
    Fernandez, Veronica
    Stoecklein, Heike
    Hernandez, Luis
    Campo, Elias
    Rosenwald, Andreas
    HAEMATOLOGICA, 2007, 92 (04) : 574 - 575
  • [46] Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
    Yoneda, Tomoko
    Kuboyama, Ayumi
    Kato, Kiyoko
    Ohgami, Tatsuhiro
    Okamoto, Kanako
    Saito, Toshiaki
    Wake, Norio
    ONCOLOGY REPORTS, 2013, 30 (01) : 25 - 34
  • [47] Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk
    Samuel, Nardin
    Id Said, Badr
    Guha, Tanya
    Novokmet, Ana
    Li, Weili
    Silwal-Pandit, Laxmi
    Borrsen-Dale, Anne-Lise
    Langerod, Anita
    Hudson, Thomas J.
    Malkin, David
    HUMAN MUTATION, 2017, 38 (03) : 265 - 268
  • [48] Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk
    Fu, Qiang
    Zhang, Guoqiang
    Chen, Hongwei
    Zheng, Youwei
    Cheng, Jing
    TUMOR BIOLOGY, 2013, 34 (06) : 3721 - 3729
  • [49] Association Between MDM2 SNP309 T>G and Risk of Gastric Cancer: A Meta-analysis
    Tian, Xin
    Tian, Ye
    Ma, Ping
    Sui, Cheng-Guang
    Meng, Fan-Dong
    Li, Yan
    Fu, Li-Ye
    Jiang, Tao
    Wang, Yang
    Ji, Fu-jian
    Fang, Xue-dong
    Jiang, You-Hong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (03) : 1925 - 1929
  • [50] MDM2 SNP309 and p53 Arg72Pro in cutaneous melanoma: association between SNP309 GG genotype and tumor Breslow thickness
    Capasso, Mario
    Ayala, Fabrizio
    Avvisati, Rosa Anna
    Russo, Roberta
    Gambale, Antonella
    Mozzillo, Nicola
    Ascierto, Paolo Antonio
    Iolascon, Achille
    JOURNAL OF HUMAN GENETICS, 2010, 55 (08) : 518 - 524
12345